Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002424

Director bought 7,173 shares at $0.74 ($5,308)

From the SEC's structured data for this filing

Trades in this filing

Gumulka Jerzy · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-10 Purchase : show line 1 in the form +7,173 $0.74 $5,308 7,173 D
Open-market purchases · 7,173 sh · avg $0.74 · $5,308
Loading xslF345X04/ownership.xml…